Remed Co Ltd (302550)

Currency in KRW
2,585
-5(-0.19%)
Closed·
302550 is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
2,4552,585
52 wk Range
2,0454,070
Key Statistics
Bid/Ask
2,505.00 / 2,550.00
Prev. Close
2,590
Open
2,585
Day's Range
2,455-2,585
52 wk Range
2,045-4,070
Volume
28.4K
Average Volume (3m)
386.47K
1-Year Change
-17.0144%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
302550 Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Prominent player in the Healthcare Equipment & Supplies industry

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Neutral
Technical Indicators
Strong Sell
Moving Averages
Strong Buy

Earnings

Latest Release
Nov 12, 2026
EPS / Forecast
17.00 / --
Revenue / Forecast
7.67B / --
EPS Revisions
Last 90 days

302550 Income Statement

Compare 302550 to Peers and Sector

Metrics to compare
302550
Peers
Sector
Relationship
P/E Ratio
36.0x3.5x−0.2x
PEG Ratio
−0.900.010.00
Price/Book
2.0x0.8x2.6x
Price / LTM Sales
2.6x1.3x2.6x
Upside (Analyst Target)
-118.0%76.9%
Fair Value Upside
Unlock34.5%14.9%Unlock

Remed Co.,Ltd. engages in the manufacture and supply of medical devices worldwide. The company offers transcranial magnetic stimulator, a technology for the treatment of disorders, such as stroke, autism, dementia, Parkinson's disease, developmental disorders, and tinnitus. It also offers neuro magnetic stimulation systems for helping blood circulation, treating pain, neurons, regenerating cells, and contraction and relaxation of muscles, as well as core muscle strengthening magnetic stimulation to enable building toned and shaped muscles. In addition, the company provides extracorporeal shock wave therapy; and technology to activate the sensory function of prostate and strengthen the pelvic floor muscle by stimulating them with electromagnetic pulse. The company was formerly known as CR Technology Co., Ltd. and changed its name to Remed Co., Ltd. in 2013. Remed Co., Ltd. was founded in 2003 and is headquartered in Daejeon, South Korea.

Ownership

Ownership Overview

Type
Common Stock Held% of Shares OutstandingMarket Value
Mutual Funds & ETFs
0.000.00%0.00
Other Institutional Investors
1.80M6.11%4.66B
Public Companies & Retail Investors
27.70M93.89%71.59B
Total
29.5M100.00%76.25B

Top Holders

Holder
% of holding
Shares Held
Date Reported
Value (In 1,000s)
MedTech Investment Fund 16.11%1,802,4514,659,336

FAQ

What Is the Remed (302550) Stock Price Today?

The Remed stock price today is 2,585 KRW.

What Stock Exchange Does Remed Trade On?

Remed is listed and trades on the KOSDAQ.

What Is the Stock Symbol for Remed?

The stock symbol for Remed is "302550."

What Is the Remed Market Cap?

As of today, Remed market cap is 76.25B KRW.

What Is Remed's Earnings Per Share (TTM)?

The Remed EPS (TTM) is 69.49.

From a Technical Analysis Perspective, Is 302550 a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Buy.

How Many Times Has Remed Stock Split?

Remed has split 1 times.

How Many Employees Does Remed Have?

Remed has 88 employees.

What is the current trading status of Remed (302550)?

As of Nov 21, 2026, Remed (302550) is trading at a price of 2,585 KRW, with a previous close of 2,590 KRW. The stock has fluctuated within a day range of 2,455 KRW to 2,585 KRW, while its 52-week range spans from 2,045 KRW to 4,070 KRW.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.